标题：北京地区军队干部冠心病患者二级预防用药依从性随访研究

      作者：杨 静 1，陈光辉 1*，王建国 2
    （1.中国人民解放军总医院心血管内科，北京 100853；
2.总参卫生局，北京 100624）

      卷次： 2012年23卷5期

      【摘要】 目的 分析军队干部冠心病（CHD）患者二级预防用药依从性的现状、影响因素，探讨解决办法。
方法 对我院 2008年 1月至 2011年 1月期间确诊的 871例冠心病患者半年后进行随访，参考Mofisky-Green
(MG)测评表进行依从性评判，分为依从性好组和依从性差组，对其影响因素进行统计分析。结果 871例患者
中依从性差组138例(15.8%)，依从性好组733例(84.2%)，两组在文化程度、职业、医患关系、发病次数、对冠心病
的了解、医生随诊方面差异有统计学意义(P＜0.05)。结论 冠心病患者药物治疗依从性差者，影响因素较多，应
针对相关因素实施对策以提高服药依从性。

      【关键词】 冠心病；二级预防；依从性

      【中图分类号】 R541.4 【文献标识码】 A 【文章编号】 1003—6350（2012）05—130—03<

br>作者简介:杨 静（1976—），女，河南省新乡市人，主治医师，在读硕士。
*通讯作者：陈光辉。E-mail：chenkevin301@ msn.
com。
·调查研究·doi:10.3969/j.issn.1003-6350.2012.05.058 Compliance in secondary prevention of coronary heart disease: a follow-up study on military man in
Beijing city，China. YANG Jing 1, CHEN Guang-hui 1*, WANG Jian-guo 2. 1. Department of Cardiology, The
General Hospital of Chinese People's Liberation Arm, Beijing 100853, CHINA; 2. Health Bureau of the General Staff,
Beijing 100624, CHINA

【Abstract】 Objective To analyze the compliance in secondary prevention of coronary heart disease (CHD)
and its influence factors. Methods From January 2008 to January 2011, 871 CHD patients diagnosed in our hospital
were followed up for 6 months and divided into two groups according to Mofisky-Green (MG): good compliance
group and bad compliance group. The influencce factors of compliance were analyzed. Results Of the 871 patients,
138 (15.8%) were found with bad compliance (bad compliance group), and 733 (84.2%) were found with good compli-
ance (good compliance group). Patients in the two groups showed statistically significant difference in educational lev-
el, occupation, doctor-patient relationship, comprehension about CHD, frequency of onset and doctor's follow-up (P<
0.05). Conclusion There were many factors that influence the compliance in secondary prevention of CHD. We
should take corresponding measures to improve the compliance.

      【Key words】 Coronary heart disease; Secondary prevention; Compliance
placement in South Korea: national registry data [J]. Rheumatology